Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Change in Receivables (2020 - 2025)

Volitionrx (VNRX) has disclosed Change in Receivables for 7 consecutive years, with $119488.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Receivables fell 18.35% year-over-year to $119488.0, compared with a TTM value of -$3526.0 through Sep 2025, down 101.72%, and an annual FY2024 reading of -$132045.0, down 177.83% over the prior year.
  • Change in Receivables was $119488.0 for Q3 2025 at Volitionrx, up from $1767.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $230928.0 in Q3 2023 and bottomed at -$315079.0 in Q2 2023.
  • Average Change in Receivables over 5 years is $7948.1, with a median of $5556.0 recorded in 2021.
  • The sharpest move saw Change in Receivables crashed 5783.47% in 2021, then soared 7805.31% in 2023.
  • Year by year, Change in Receivables stood at -$24926.0 in 2021, then crashed by 163.38% to -$65649.0 in 2022, then surged by 305.98% to $135225.0 in 2023, then plummeted by 249.41% to -$202037.0 in 2024, then soared by 159.14% to $119488.0 in 2025.
  • Business Quant data shows Change in Receivables for VNRX at $119488.0 in Q3 2025, $1767.0 in Q2 2025, and $77256.0 in Q1 2025.